Company intelligence / Profile preview

Mor Research Applications

Tel Aviv, Israel
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

Mor Research Applications is the technology transfer office (TTO) of Clalit Health Services, commercializing inventions from Clalit’s hospitals and clinics across medical devices, pharma, diagnostics, digital health, and biotech; it manages patents, early funding and out‑licensing or spin‑out company creation but does not itself run a defined drug development pipeline.[1][3][4]

Modalities
Small moleculeBiologicMonoclonal antibodyMedical deviceDigital healthDiagnosticVaccineCell therapyGene therapy
Industry
Investors
02

Partnerships

Clalit Health Services

Beyond the preview

Go deeper on Mor Research Applications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mor Research Applications.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call